Cargando...
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
BACKGROUND: Despite the current treatments available for panic disorder (PD), as many as one-third of patients have persistent and treatment-resistant panic attacks. Vortioxetine is an approved medicine for major depressive disorder and has been shown to have anxiolytic properties. The purpose of th...
Gardado en:
| Publicado en: | Ann Gen Psychiatry |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5946398/ https://ncbi.nlm.nih.gov/pubmed/29760763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12991-018-0190-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|